CCM
LEGN icon

Coldstream Capital Management’s Legend Biotech LEGN Stock Holding History

Coldstream Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-144
Closed -$4.89K – 2326
2025
Q1 		$4.89K Buy
+144
New +$5.16K ﹤0.01% 2708

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Coldstream Capital Management's LEGN Position: Q2 2025 in Review

Coldstream Capital Management sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 144 shares — an estimated $4.89K sold.

Coldstream Capital Management first reported a position in LEGN in Q1 2025 and held it in 1 quarter. The position peaked at $4.89K in Q1 2025. 210 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Coldstream Capital Management reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 144 Legend Biotech shares in Q2 2025, an estimated $4.89K.
  • Coldstream Capital Management first reported a position in Legend Biotech in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Legend Biotech position peaked at $4.89K in Q1 2025.
  • 210 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.